HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance

Detalles Bibliográficos
Autores principales: Pascut, Devis, Pratama, Muhammad Yogi, Tiribelli, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336296/
https://www.ncbi.nlm.nih.gov/pubmed/32647566
http://dx.doi.org/10.2217/hep-2020-0010
_version_ 1783554290303893504
author Pascut, Devis
Pratama, Muhammad Yogi
Tiribelli, Claudio
author_facet Pascut, Devis
Pratama, Muhammad Yogi
Tiribelli, Claudio
author_sort Pascut, Devis
collection PubMed
description
format Online
Article
Text
id pubmed-7336296
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-73362962020-07-08 HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance Pascut, Devis Pratama, Muhammad Yogi Tiribelli, Claudio Hepat Oncol Editorial Future Medicine Ltd 2020-06-22 /pmc/articles/PMC7336296/ /pubmed/32647566 http://dx.doi.org/10.2217/hep-2020-0010 Text en © 2020 Devis Pascut https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Editorial
Pascut, Devis
Pratama, Muhammad Yogi
Tiribelli, Claudio
HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
title HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
title_full HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
title_fullStr HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
title_full_unstemmed HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
title_short HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
title_sort hcc occurrence after daa treatments: molecular tools to assess the post-treatment risk and surveillance
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336296/
https://www.ncbi.nlm.nih.gov/pubmed/32647566
http://dx.doi.org/10.2217/hep-2020-0010
work_keys_str_mv AT pascutdevis hccoccurrenceafterdaatreatmentsmoleculartoolstoassesstheposttreatmentriskandsurveillance
AT pratamamuhammadyogi hccoccurrenceafterdaatreatmentsmoleculartoolstoassesstheposttreatmentriskandsurveillance
AT tiribelliclaudio hccoccurrenceafterdaatreatmentsmoleculartoolstoassesstheposttreatmentriskandsurveillance

Ejemplares similares